Somaxon Pharmaceuticals, Inc. 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Jun 5, 2007
Insider Transaction Report
Form 4
McGilley Meg
VP, CFO, Treasurer
Transactions
- Exercise/Conversion
Common Stock
2007-06-01$1.20/sh+4,000$4,800→ 4,000 total - Sale
Common Stock
2007-06-01$14.80/sh−4,200$62,160→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2007-06-01−4,000→ 12,500 totalExercise: $1.20Exp: 2014-06-27→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2007-06-01−200→ 29,800 totalExercise: $2.40Exp: 2015-03-01→ Common Stock (200 underlying) - Exercise/Conversion
Common Stock
2007-06-01$2.40/sh+200$480→ 4,200 total
Footnotes (4)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2006, as amended to date.
- [F2]No shares of common stock subject to the option are vested and exercisable as of June 5, 2007 and approximately 1,041 vest and become exercisable on the first day of each month.
- [F3]Not applicable to this transaction.
- [F4]16,675 shares of common stock subject to the option are vested and exercisable as of June 5, 2007 and approximately 625 vest and become exercisable on the first day of each month.